New Collaboration Project Was Approved by Bina Nurture Committee
Bina is pleased to announce the launch of a newly approved collaborative research project, which brings together expertise from two leading research institutions.The project is a collaboration between Dr. Haim Barr, Head of the Maurice and Vivienne Wohl Institute for Drug Discovery at the Weizmann Institute of Science, and Prof. Yossi (Joseph) Tam from the Institute for Drug Research at the School of Pharmacy, The Hebrew University of Jerusalem.The shared objective of this collaboration is to identify a highly specific inhibitor targeting a key protein, with the long-term goal of advancing novel therapeutic strategies for the treatment of metabolic syndrome.Scientific guidance and mentorship are provided by Dr. Merav Marom (Bina), Dr. Shiraz Kalir (Yissum), and Dr. Jacob F. (Yeda), whose combined expertise significantly strengthens the project’s scientific and translational framework.This collaboration highlights the value of interdisciplinary research, integrating drug discovery, pharmacology, and translational science to address unmet needs in the treatment of metabolic diseases.